NCT02858791View on ClinicalTrials.gov

MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension

CompletedOBSERVATIONAL
Enrollment

99

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 21, 2017

Study Completion Date

December 21, 2017

Conditions
Pulmonary HypertensionPulmonary Arterial HypertensionInterstitial Lung Disease
Trial Locations (1)

11040

Northwell Health, New Hyde Park

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
lead

Northwell Health

OTHER

NCT02858791 - MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter